- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology, October 2022
Adopting Smart Development Strategies
October 03, 2022
Cover Story
46
10
External expertise is beneficial in helping companies select the right tools at the right stages of development to ensure success.
Application of F Charts in Continued Process Verification of OSD Forms
October 03, 2022
Peer-Reviewed Research
46
10
This article introduces a control chart technique using F statistic for continued process verification of oral solid dosage forms.
Reformulating Success
October 03, 2022
Development
46
10
There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.
Analyzing Extractables and Leachables in Single-Use Systems
October 03, 2022
Analytics
46
10
Standardized risk assessment and analysis protocols facilitate the comparison of processing equipment components.
Improving Sterility Using Blow-Fill-Seal Technology
October 03, 2022
Manufacturing
46
10
BFS technology can help maintain sterility during the biologics manufacturing process.
Electrochemistry for API Synthesis
October 03, 2022
Development
46
10
Numerous benefits will eventually lead to large-scale applications in pharmaceutical manufacturing.
Shining a Light on Lipid Nanoparticle Characterization
October 03, 2022
Development
46
10
Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.
The Future of Drug Delivery for Biopharmaceuticals
October 03, 2022
Development
46
10
Some of the greatest advancements in drug delivery are related to disposable delivery devices, vaccine adjuvants, and wearable pumps, according to Nicholas W. Warne of Pfizer.
The State of Contamination Control
October 03, 2022
Manufacturing
46
10
Various advances in contamination control are being utilized to reduce the chance pollutants contaminate a drug product.
Biologic Standards in the Pharmacopoeias: An Update
October 02, 2022
Quality/Regulations
46
10
Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.
Choosing the Right CDMO for CGT Programs
October 02, 2022
Outsourcing
46
10
Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.
The Future of Pharmaceutical Environmental Monitoring in Europe
October 02, 2022
Manufacturing
46
10
A blended approach to newly revised regulatory guidance to inform environmental monitoring programmes is essential.
Growth in Cell and Gene Therapy Market
October 02, 2022
Weighing Up Big Pharma
46
10
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
A Royal Tribute
October 02, 2022
From The Editor
46
10
Pharmaceutical Technology Europe pays tribute to the role Her Majesty Queen Elizabeth II had in promoting innovation within life sciences.
Securing Europe’s Critical Entities from Cyber Attacks
October 02, 2022
Regulatory Watch
46
10
Under the revised NIS-2 Directive in Europe, pharma companies will need to be proactive in safeguarding their digital assets.
Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing
October 02, 2022
Regulatory Watch
46
10
FDA backs joint reviews, common research policies, and modern production methods around the world.
Industry’s Best Secret
October 02, 2022
From The Editor
46
10
One can only learn the secrets of "fight club" by attending its meetings.
Regulatory Compliance Versus Real Compliance
October 02, 2022
Ask the Expert
46
10
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, addresses the difference between regulatory compliance and real compliance.
Ergonomic, Safety-Focused Blenders
October 02, 2022
Product Spotlight
46
10
ROSS Ribbon Blenders are a customizable solution designed to minimize risk and maximize productivity.
Inorganic DNA Replication Enzyme
October 02, 2022
Product Spotlight
46
10
The new inorganic pyrophosphate from Canvax is intended for use in RNA IVT reactions.
Continuous Granulator with Integrated Dryer
October 02, 2022
Product Spotlight
46
10
L.B. Bohle’s QbCon 1 is intended to meet all quality requirements for long granulation processing time.
Next-Generation Synthetic Biology Workflow Platform
October 02, 2022
Product Spotlight
46
10
Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.
Optimizing Quality
October 02, 2022
From the CEO
46
10
The 1VQ papers advocate for the idea that certain post-approval changes should be streamlined and expedited.